← Leaderboards
Loren D Walensky
Northeastern University
$48,447,848
Attributed
$58,496,050
Total exposure
10
Grants
9
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $4.5M · FY2005–25$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$58,496,050 · 10
By mechanism
T32$34,310,763 · 2
R35$11,425,117 · 1
R01$10,035,081 · 4
P01$1,648,951 · 1
K08$657,450 · 1
R21$418,688 · 1
Top collaborators
- David Shumway Jones8 shared
- Jacqueline A. Lees8 shared
- Andrea E Reid8 shared
- John R Engen3 shared
- Thomas Edward Wales2 shared
Most similar at Northeastern University
Same institution · by research overlap
- Thomas Edward Wales$464,043
Others in their field
Top investigators on “Proteins”
- David Heimbrook · Leidos Biomedical Research, Inc.$354,061,551
- Randall J Bateman · Washington University$187,292,085
- Paul S. Aisen · Cognition Therapeutics, Inc.$175,382,342
- Reisa A. Sperling · Banner Health$145,046,481
- Barton F Haynes · Duke University$136,029,850
- Joseph L Goldstein · University Of Texas Sw Med Ctr/Dallas$102,433,280
Research focus
ProteinsCellsStructureChemistryMedicalResistanceTraining ProgramsMediatingInsightMalignant NeoplasmsScientistFamilyPeptidesPrototypePathway InteractionsIn VivoBiologyMolecularInterdisciplinary ApproachApoptoticBiologicalProtein FamilyHydrocarbonsStructural Biology
Grant awards (73)
Medical Scientist Training Program$2,798,162
T32 · FY2025 · GM · contact PI
Dissecting and Targeting Deregulated Mitochondrial Apoptosis in Human Cancer$1,052,251
R35 · FY2025 · CA · contact PI
Medical Scientist Training Program$60,545
T32 · FY2025 · GM · contact PI
Medical Scientist Training Program$2,876,924
T32 · FY2024 · GM · contact PI
Dissecting and Targeting Deregulated Mitochondrial Apoptosis in Human Cancer$999,639
R35 · FY2024 · CA · contact PI
Conformational Regulation and Therapeutic Targeting of Oncogenic KRAS$456,831
R01 · FY2024 · CA
Medical Scientist Training Program$119,872
T32 · FY2024 · GM · contact PI
Medical Scientist Training Program$2,786,569
T32 · FY2023 · GM · contact PI
Dissecting and Targeting Deregulated Mitochondrial Apoptosis in Human Cancer$1,031,206
R35 · FY2023 · CA · contact PI
Conformational Regulation and Therapeutic Targeting of Oncogenic KRAS$471,255
R01 · FY2023 · CA
Medical Scientist Training Program$116,107
T32 · FY2023 · GM · contact PI
Medical Scientist Training Program$2,737,736
T32 · FY2022 · GM · contact PI
Dissecting and Targeting Deregulated Mitochondrial Apoptosis in Human Cancer$1,031,206
R35 · FY2022 · CA · contact PI
Conformational Regulation and Therapeutic Targeting of Oncogenic KRAS$471,255
R01 · FY2022 · CA
Medical Scientist Training Program$285,180
T32 · FY2022 · GM · contact PI
Medical Scientist Training Program$2,572,408
T32 · FY2021 · GM · contact PI
Dissecting and Targeting Deregulated Mitochondrial Apoptosis in Human Cancer$1,071,751
R35 · FY2021 · CA · contact PI
Conformational Regulation and Therapeutic Targeting of Oncogenic KRAS$480,873
R01 · FY2021 · CA
Medical Scientist Training Program$53,763
T32 · FY2021 · GM · contact PI
Medical Scientist Training Program$53,763
T32 · FY2021 · GM · contact PI
Medical Scientist Training Program$53,763
T32 · FY2021 · GM · contact PI
Medical Scientist Training Program$2,553,869
T32 · FY2020 · GM · contact PI
Dissecting and Targeting Deregulated Mitochondrial Apoptosis in Human Cancer$1,045,401
R35 · FY2020 · CA · contact PI
Conformational Regulation and Therapeutic Targeting of Oncogenic KRAS$544,547
R01 · FY2020 · CA
Medical Scientist Training Program$53,206
T32 · FY2020 · GM · contact PI
Medical Scientist Training Program$2,527,741
T32 · FY2019 · GM · contact PI
Dissecting and Targeting Deregulated Mitochondrial Apoptosis in Human Cancer$1,014,038
R35 · FY2019 · CA · contact PI
Medical Scientist Training Program$105,323
T32 · FY2019 · GM · contact PI
Medical Scientist Training Program$2,502,236
T32 · FY2018 · GM · contact PI
Dissecting and Targeting Deregulated Mitochondrial Apoptosis in Human Cancer$1,045,401
R35 · FY2018 · CA · contact PI
Medical Scientist Training Program$52,130
T32 · FY2018 · GM · contact PI
Medical Scientist Training Program$2,477,353
T32 · FY2017 · GM · contact PI
Dissecting and Targeting Deregulated Mitochondrial Apoptosis in Human Cancer$1,045,401
R35 · FY2017 · CA · contact PI
Biophysical and Mechanistic Determinants for Cancer Cell Import of Hydrocarbon-Stapled Peptides$228,375
R21 · FY2017 · CA · contact PI
Medical Scientist Training Program$51,612
T32 · FY2017 · GM · contact PI
Medical Scientists Training Program$2,446,979
T32 · FY2016 · GM · contact PI
Dissecting and Targeting Deregulated Mitochondrial Apoptosis in Human Cancer$1,045,401
R35 · FY2016 · CA · contact PI
Biophysical and Mechanistic Determinants for Cancer Cell Import of Hydrocarbon-Stapled Peptides$190,313
R21 · FY2016 · CA · contact PI
Medical Scientists Training Program$153,318
T32 · FY2016 · GM · contact PI
Medical Scientists Training Program$2,429,453
T32 · FY2015 · GM · contact PI
Dissecting and Targeting Deregulated Mitochondrial Apoptosis in Human Cancer$1,043,422
R35 · FY2015 · CA · contact PI
Medical Scientists Training Program$151,842
T32 · FY2015 · GM · contact PI
Medical Scientists Training Program$2,005,360
T32 · FY2014 · GM · contact PI
Protein Interaction Extends the Cell Death Pathway$417,284
R01 · FY2014 · CA · contact PI
Medical Scientists Training Program$150,402
T32 · FY2014 · GM · contact PI
Medical Scientists Training Program$1,986,182
T32 · FY2013 · GM · contact PI
A Lexicon of Stapled Peptide Helices Engineered to Capture the Protein Interactom$415,930
R01 · FY2013 · GM · contact PI
Protein Interaction Extends the Cell Death Pathway$398,913
R01 · FY2013 · CA · contact PI
Medical Scientists Training Program$148,965
T32 · FY2013 · GM · contact PI
A Lexicon of Stapled Peptide Helices Engineered to Capture the Protein Interactom$428,794
R01 · FY2012 · GM · contact PI
Stapled Antigens for HIV-1 Vaccination$428,794
R01 · FY2012 · AI · contact PI
Protein Interaction Extends the Cell Death Pathway$424,375
R01 · FY2012 · CA · contact PI
A Lexicon of Stapled Peptide Helices Engineered to Capture the Protein Interactom$428,794
R01 · FY2011 · GM · contact PI
Stapled Antigens for HIV-1 Vaccination$428,794
R01 · FY2011 · AI · contact PI
Protein Interaction Extends the Cell Death Pathway$424,375
R01 · FY2011 · CA · contact PI
Protein Interaction Extends the Cell Death Pathway$436,667
R01 · FY2010 · CA · contact PI
A Lexicon of Stapled Peptide Helices Engineered to Capture the Protein Interactom$432,712
R01 · FY2010 · GM · contact PI
Stapled Antigens for HIV-1 Vaccination$432,712
R01 · FY2010 · AI · contact PI
Targeting Deregulated Apoptotic and Transcriptional Programs in Lymphoma$369,874
P01 · FY2010 · CA · contact PI
Stapled Antigens for HIV-1 Vaccination$432,084
R01 · FY2009 · AI · contact PI
A Lexicon of Stapled Peptide Helices Engineered to Capture the Protein Interactom$432,083
R01 · FY2009 · GM · contact PI
Protein Interaction Extends the Cell Death Pathway$431,667
R01 · FY2009 · CA · contact PI
Targeting Deregulated Apoptotic and Transcriptional Programs in Lymphoma$368,077
P01 · FY2009 · CA · contact PI
Targeting Deregulated Apoptotic and Transcriptional Programs in Lymphoma$310,759
P01 · FY2008 · CA · contact PI
Targeting Deregulated Apoptotic and Transcriptional Programs in Lymphoma$303,637
P01 · FY2007 · CA · contact PI
Targeting Apoptosis by Chemical Design$131,490
K08 · FY2007 · HL · contact PI
Protein Interaction Extends the Cell Death Pathway$609,928
R01 · FY2006 · CA · contact PI
Targeting Deregulated Apoptotic and Transcriptional Programs in Lymphoma$296,604
P01 · FY2006 · CA · contact PI
Targeting Apoptosis by Chemical Design$131,490
K08 · FY2006 · HL · contact PI
Protein Interaction Extends the Cell Death Pathway$606,414
R01 · FY2005 · CA
Targeting Apoptosis by Chemical Design$131,490
K08 · FY2005 · HL
Targeting Apoptosis by Chemical Design$131,490
K08 · FY2004 · HL
Targeting Apoptosis by Chemical Design$131,490
K08 · FY2003 · HL